AKT1 and cancer: ERRα/PGC-1α/β activity is under the regulation of several oncogenic signals, including the PI3K/AKT/mTOR pathway which plays a key role in activating SREBP, a critical transcription factor involved in intracellular cholesterol synthesis in cancer cells [55].